Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 13, 2023
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
David Westenberg Maintained (AKYA) at Buy with Decreased Target to $8 on, Nov 13th, 2023
David Westenberg of Piper Sandler, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $11 to $8 on, Nov 13th, 2023.
David has made no other calls on AKYA in the last 4 months.
There are 2 other peers that have a rating on AKYA. Out of the 2 peers that are also analyzing AKYA, 0 agree with David's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with David
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $8 on, Tuesday, October 24th, 2023
- John Sourbeer of "UBS" Maintained at Strong Buy with Decreased Target to $7 on, Thursday, October 12th, 2023
